-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Id+K8raFZIYiue+ER7I5EmgoRc+dsFQcC9/AcsOm9VdD/7iVOGsDF3Ognr2dpu0D GeGH3Vo9mTBQwwT633TVmw== 0001209191-05-059403.txt : 20051123 0001209191-05-059403.hdr.sgml : 20051123 20051123113850 ACCESSION NUMBER: 0001209191-05-059403 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051122 FILED AS OF DATE: 20051123 DATE AS OF CHANGE: 20051123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WORMUTH DAVID E CENTRAL INDEX KEY: 0001251780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-13789 FILM NUMBER: 051223561 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4259083600 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-11-22 0 0000737207 NASTECH PHARMACEUTICAL CO INC NSTK 0001251780 WORMUTH DAVID E 3450 MONTE VILLA PARKWAY BOTHELL WA 98021 0 1 0 0 Sr VP, Operations & Mfg Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 M 0 10000 4.625 A 17500 D Nastech Pharmaceutical Company Inc Common Stock 2005-10-24 4 S 0 1700 13.94 D 15800 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 800 13.95 D 15000 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 700 13.96 D 14300 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 900 13.97 D 13400 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 700 13.98 D 12700 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 400 13.99 D 12300 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 600 14.00 D 11700 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 100 14.03 D 11600 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 400 14.04 D 11200 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 400 14.05 D 10800 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 200 14.06 D 10600 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 100 14.07 D 10500 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 200 14.09 D 10300 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 200 14.10 D 10100 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 200 14.12 D 9900 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 200 14.14 D 9700 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 500 14.17 D 9200 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 200 14.18 D 9000 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 300 14.21 D 8700 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 300 14.24 D 8400 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 300 14.27 D 8100 D Nastech Pharmaceutical Company Inc Common Stock 2005-11-22 4 S 0 600 14.30 D 7500 D Nastech Pharmaceutical Company Inc Stock Options 4.625 2005-11-22 4 X 0 10000 4.625 D 2004-03-23 2006-03-23 Common Stock 10000 85000 D Exercise and sale of options pursuant to 10B5-1 Trading Plan adopted July 13, 2005. /s/ Philip C. Ranker Philip C. Ranker Attorney in Fact 2005-11-23 -----END PRIVACY-ENHANCED MESSAGE-----